Structure-based drug design with geometric deep learning
Structure-based drug design uses three-dimensional geometric information of macromolecules, such as proteins or nucleic acids, to identify suitable ligands. Geometric deep learning, an emerging concept of neural-network-based machine learning, has been applied to macromolecular structures. This review provides an overview of the recent applications of geometric deep learning in bioorganic and medicinal chemistry, highlighting its potential for structure-based drug discovery and design. Emphasis is placed on molecular property prediction, ligand binding site and pose prediction, and structure-based de novo molecular design. The current challenges and opportunities are highlighted, and a forecast of the future of geometric deep learning for drug discovery is presented.
Code (0)
등록된 구현이 없습니다.
Tasks
Deep LearningDrug DesignDrug DiscoveryMolecular Property PredictionPose PredictionPredictionProperty PredictionSimilar Papers 제목 키워드 기반
Contrastive Geometric Learning Unlocks Unified Structure- and Ligand-Based Drug Design
Structure-based and ligand-based computational drug design have traditionally relied on disjoint data sources and modeling assumptions, limiting their joint use at scale. In this work, we introduce Contrastive Geometric …
Contrastive LearningDrug DiscoveryGeometric-informed GFlowNets for Structure-Based Drug Design
The rise of cost involved with drug discovery and current speed of which they are discover, underscore the need for more efficient structure-based drug design (SBDD) methods. We employ Generative Flow Networks (GFlowNets…
Drug DesignDrug DiscoveryTailoring Molecules for Protein Pockets: a Transformer-based Generative Solution for Structured-based Drug Design
Structure-based drug design is drawing growing attentions in computer-aided drug discovery. Compared with the virtual screening approach where a pre-defined library of compounds are computationally screened, de novo drug…
DecoderDrug DesignDrug DiscoverySculptDrug : A Spatial Condition-Aware Bayesian Flow Model for Structure-based Drug Design
Structure-Based drug design (SBDD) has emerged as a popular approach in drug discovery, leveraging three-dimensional protein structures to generate drug ligands. However, existing generative models encounter several key …
Drug DiscoveryKnowledge Guided Geometric Editing for Unsupervised Drug Design
Deep learning models have been widely used in automatic drug design. Current deep approaches always represent and generate candidate molecules as a 1D string or a 2D graph, which rely on large measurement data from lab e…
Drug Design